Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions

被引:44
作者
Koskinas, Konstantinos C. [1 ]
Ndrepepa, Gjin [2 ]
Raeber, Lorenz [1 ]
Karagiannis, Alexios [3 ,4 ]
Kufner, Sebastian [2 ]
Zanchin, Thomas [1 ]
Hieber, Julia [2 ]
Hunziker, Lukas [1 ]
Mayer, Katharina [2 ]
Byrne, Robert A. [2 ,5 ]
Heg, Dik [3 ,4 ]
Windecker, Stephan [1 ]
Kastrati, Adnan [2 ,5 ]
机构
[1] Bern Univ Hosp, Dept Cardiol, CH-3010 Bern, Switzerland
[2] Tech Univ, Deutsch Herzzentrum Munchen, Dept Adult Cardiol, Munich, Germany
[3] Univ Bern, CTU Bern, Bern, Switzerland
[4] Univ Bern, ISPM, Bern, Switzerland
[5] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany
关键词
coronary artery disease; myocardial infarction; prognosis; troponin; TROPONIN-T; DEFINITION; MORTALITY; ELEVATION; EVENTS;
D O I
10.1161/CIRCINTERVENTIONS.118.006752
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The magnitude of prognostically relevant myocardial injury after percutaneous coronary interventions remains poorly defined. The Society for Cardiovascular Angiography and Interventions (SCAI) proposed marked biomarker elevations to define periprocedural myocardial infarction (PMI). These consensus-based thresholds have not been validated in the era of high-sensitivity cardiac troponins. We sought to assess the prognostic impact of SCAI-defined PMI and explore optimal prognostic thresholds of high-sensitivity cardiac troponin T (hs-cTnT) after elective percutaneous coronary interventions. METHODS AND RESULTS: We evaluated patients who underwent elective percutaneous coronary interventions at 2 tertiary care centers with serial hs-cTnT measurements. PMI was defined as peak postprocedural hs-cTnT > 70x upper reference limit (URL) in patients with nonelevated (<= 1x URL) baseline levels; or incremental increase > 70x URL in patients with elevated baseline levels. The primary outcome was 1-year all-cause mortality. Of 8140 patients, 220 (2.7%) died within 1 year. In multivariable analyses, patients with SCAI-defined PMI (n= 140; 1.7%) had a higher risk of 1-year mortality (12.9% versus 2.5%, adjusted hazard ratio 4.10, 95% CI 2.51-6.68; P< 0.001) as well as cardiac mortality (11.4% versus 2.1%, adjusted hazard ratio 4.21, 95% CI 2.50-7.11; P< 0.001). Based on receiver operating characteristics analysis, the optimal prognostic threshold of hs-cTnT was > 10xURL, observed in 14.6% of patients. This threshold showed lower specificity (85.7% versus 98.4%) but higher sensitivity (25.4% versus 8.2%) and better overall performance for prediction of 1-year mortality compared with the SCAI-defined cutoff value of troponin. CONCLUSIONS: In patients undergoing elective percutaneous coronary interventions, SCAI-defined PMI emerged as an independent, highly specific, but insensitive predictor of 1-year mortality. Optimal trade-off between sensitivity and specificity was observed at a lower threshold of hs-cTnT (10x URL) in this cohort.
引用
收藏
页数:11
相关论文
共 26 条
[1]   Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions [J].
Cho, Min Soo ;
Ahn, Jung-Min ;
Lee, Cheol-Hyun ;
Kang, Do-Yoon ;
Lee, Jung-Bok ;
Lee, Pil Hyung ;
Kang, Soo-Jin ;
Lee, Seung-Whan ;
Kim, Young-Hak ;
Lee, Cheol Whan ;
Park, Seong-Wook ;
Park, Duk-Woo ;
Park, Seung-Jung .
JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (15) :1498-1507
[2]   An application of changepoint methods in studying the effect of age on survival in breast cancer [J].
Contal, C ;
O'Quigley, J .
COMPUTATIONAL STATISTICS & DATA ANALYSIS, 1999, 30 (03) :253-270
[3]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[4]   Incidence, predictors and longer-term impact of troponin elevation following hybrid chronic total occlusion percutaneous coronary intervention [J].
Dautov, Rustem ;
Ybarra, Luiz Fernando ;
Can Manh Nguyen ;
Gibrat, Claire ;
Joyal, Dominique ;
Rinfret, Stephane .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (05) :E308-E316
[5]   Increasingly Sensitive Assays for Cardiac Troponins A Review [J].
de Lemos, James A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (21) :2262-2269
[6]   High-Sensitivity Cardiac Troponin I and B-Type Natriuretic Peptide as Predictors of Vascular Events in Primary Prevention Impact of Statin Therapy [J].
Everett, Brendan M. ;
Zeller, Tanja ;
Glynn, Robert J. ;
Ridker, Paul M. ;
Blankenberg, Stefan .
CIRCULATION, 2015, 131 (21) :1851-+
[7]   Analytical Validation of a High-Sensitivity Cardiac Troponin T Assay [J].
Giannitsis, Evangelos ;
Kurz, Kerstin ;
Hallermayer, Klaus ;
Jarausch, Jochen ;
Jaffe, Allan S. ;
Katus, Hugo A. .
CLINICAL CHEMISTRY, 2010, 56 (02) :254-261
[8]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[9]  
2-4
[10]   Defining the Optimal Cardiac Troponin T Threshold for Predicting Death Caused by Periprocedural Myocardial Infarction After Percutaneous Coronary Intervention [J].
Herrmann, Joerg ;
Lennon, Ryan J. ;
Jaffe, Allan S. ;
Holmes, David R., Jr. ;
Rihal, Charanjit S. ;
Prasad, Abhiram .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (04) :533-542